The rising demand for advanced healthcare services and remote patient monitoring systems, investments by healthcare information technology (HIT) firms, and support from government organizations are driving the adoption of clinical decision support system (CDSS). From $410.5 million in 2015, the CDSS market is projected to grow at a CAGR of 21.5% during 2016–2022. CDSS is an HIT system, which helps doctors and other medical professionals with clinical decision making, thereby improving the quality of healthcare and patient outcomes.
 |
| To learn more about this report@ http://bit.ly/37XTcec |
Of the two types of solutions available — integrated and standalone — integrated solutions dominated the CDSS market during the historical period (2012–2015). Such solutions are also expected to witness the higher CAGR, of 22.4%, during the forecast period, as these are integrated with electronic health records (EHR) and computerized physician order entry (CPOE) systems, especially those that relate to drug allergy alerts, drug–drug interactions, and clinical reminders. As integrated systems help prevent medication errors, the demand for these is growing.
The increasing support for the technology from governments is also helping the market grow. For instance, under the Connecting Europe Facility, the European Union granted around $18.1 million for deploying digital service infrastructures (DSI) in the eProcurement, eHealth, online dispute resolution (ODR), and eIdentification (eID) areas. Similarly, the U.S. government has implemented the Health Information Technology for Economic and Clinical Health (HITECH) Act, which mandates the use of digital health technologies.
During the historical period, North America held the largest share in the CDSS market, in terms of value, and the same scenario is expected during the forecast period. This would be a result of the advanced healthcare infrastructure, growing geriatric population, increasing healthcare spending, and rising incidence of chronic and lifestyle-associated diseases here. As per the American Diabetes Association, the number of diabetes patients in the U.S. rose from 25.8 million in 2010 to about 29.1 million in 2012.
Therefore, with the increase in the geriatric population, which is more prone to chronic diseases and also unable to visit hospitals regularly, the demand for clinical decision support systems will continue rising.
